Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase II subunit RPB1 (RPB1) is the largest and catalytic subunit of RNA polymerase II, the enzyme complex responsible for synthesizing messenger RNA (mRNA) and many functional non-coding RNAs in eukaryotes. It is crucial for mRNA precursor synthesis and its CTD serves as a platform for assembly/regulation by various factors during transcription initiation, elongation, termination, and mRNA processing. In certain viral infections, it can act as an RNA-dependent RNA polymerase.
Inhibition of RNA Polymerase II activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA Polymerase II Subunit RPB1 (RPB1).